163 related articles for article (PubMed ID: 16873432)
1. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.
Hao RT; Zhang XH; Pan YF; Liu HG; Xiang YQ; Wan L; Wu XL
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1349-57. PubMed ID: 20140626
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.
Ren T; Jiang B; Xing X; Dong B; Peng L; Meng L; Xu H; Shou C
Pathol Oncol Res; 2009 Dec; 15(4):555-60. PubMed ID: 19247814
[TBL] [Abstract][Full Text] [Related]
4. Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer.
Ustaalioglu BB; Bilici A; Barisik NO; Aliustaoglu M; Vardar FA; Yilmaz BE; Seker M; Gumus M
Clin Transl Oncol; 2012 Dec; 14(12):911-22. PubMed ID: 22855168
[TBL] [Abstract][Full Text] [Related]
5. Combined expression of metastasis related markers Naa10p, SNCG and PRL-3 and its prognostic value in breast cancer patients.
Min L; Ma RL; Yuan H; Liu CY; Dong B; Zhang C; Zeng Y; Wang L; Guo JP; Qu LK; Shou CC
Asian Pac J Cancer Prev; 2015; 16(7):2819-26. PubMed ID: 25854368
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M
Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511
[TBL] [Abstract][Full Text] [Related]
7. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases.
Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A
Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C
Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507
[TBL] [Abstract][Full Text] [Related]
9. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer.
Radke I; Götte M; Kersting C; Mattsson B; Kiesel L; Wülfing P
Br J Cancer; 2006 Aug; 95(3):347-54. PubMed ID: 16832410
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
Reich R; Hadar S; Davidson B
Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
[TBL] [Abstract][Full Text] [Related]
13. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer.
Peng L; Ning J; Meng L; Shou C
J Cancer Res Clin Oncol; 2004 Sep; 130(9):521-6. PubMed ID: 15133662
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Zhou J; Wang S; Lu J; Li J; Ding Y
Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
[TBL] [Abstract][Full Text] [Related]
15. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.
Dai N; Lu AP; Shou CC; Li JY
World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925
[TBL] [Abstract][Full Text] [Related]
16. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
17. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.
Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X
Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129
[TBL] [Abstract][Full Text] [Related]
18. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis.
Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH
Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206
[TBL] [Abstract][Full Text] [Related]
19. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
20. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.
Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J
J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
